Patents by Inventor Rohit Malik

Rohit Malik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEM AND METHOD FOR PERFORMING VISUAL INSPECTION USING SYNTHETICALLY GENERATED IMAGES
    Publication number: 20210201474
    Abstract: A system and method for performing visual inspection using synthetically generated images is disclosed. An example embodiment is configured to: receive one or more images of a compliant manufactured component; receive images of component defects; use the images of component defects to produce a variety of different synthetically-generated images of defects; combine the synthetically-generated images of defects with the one or more images of the compliant manufactured component to produce synthetically-generated images of a non-compliant manufactured component; and collect the one or more images of the compliant manufactured component with the synthetically-generated images of the non-compliant manufactured component into a training dataset to train a machine learning system.
    Type: Application
    Filed: March 17, 2021
    Publication date: July 1, 2021
    Inventors: Sameer SHARMA, Vishwanath VENKATARAMAN, Rohit MALIK, Yousaf BILAL, Sankara J. SUBRAMANIAN
  • Compositions and methods for treating cancer
    Patent number: 11013754
    Abstract: Provided herein are compositions and methods for treating cancer. In particular, provided herein are compositions, methods, and uses of inhibitors of ARlnc1 for treating cancer.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: May 25, 2021
    Assignee: The Regents of the University of Michigan
    Inventors: Arul Chinnaiyan, Rohit Malik, Yajia Zhang, Marcin Cieslik, Sethuramasundaram Pitchiaya
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20190307787
    Abstract: Provided herein are compositions and methods for treating cancer. In particular, provided herein are compositions, methods, and uses of inhibitors of ARlnc1 for treating cancer.
    Type: Application
    Filed: April 9, 2019
    Publication date: October 10, 2019
    Inventors: Arul Chinnaiyan, Rohit Malik, Yajia Zhang, Marcin Cieslik, Sethuramasundaram Pitchiaya
  • Methods of utilizing the arrestin-2/STAM-1 complex as a therapeutic target
    Patent number: 8691188
    Abstract: Methods of utilizing the arrestin-2/sTAM-1 complex as a therapeutic target. The methods include treating cells of a living organism to mediate an interaction between arrestin-2 and STAM-1 adapter protein molecules, wherein the interaction is characterized by the arrestin-2 adapter protein molecule directly binding to the STAM-2 adapter protein molecule. Pharmacological agents can be identified for therapeutic uses by determining whether the pharmacological agent disrupts the interaction between the arrestin-2 and STAM-1 adapter protein molecules.
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: April 8, 2014
    Assignee: Loyola University Chicago
    Inventors: Adriano Marchese, Rohit Malik
  • METHODS OF UTILIZING THE ARRESTIN-2/STAM-1 COMPLEX AS A THERAPEUTIC TARGET
    Publication number: 20120059044
    Abstract: Methods of utilizing the arrestin-2/sTAM-1 complex as a therapeutic target. The methods include treating cells of a living organism to mediate an interaction between arrestin-2 and STAM-1 adapter protein molecules, wherein the interaction is characterized by the arrestin-2 adapter protein molecule directly binding to the STAM-2 adapter protein molecule. Pharmacological agents can be identified for therapeutic uses by determining whether the pharmacological agent disrupts the interaction between the arrestin-2 and STAM-1 adapter protein molecules.
    Type: Application
    Filed: May 25, 2011
    Publication date: March 8, 2012
    Applicant: LOYOLA UNIVERSITY CHICAGO
    Inventors: Adriano Marchese, Rohit Malik